US Stock Movement: Faeth Therapeutics surges on October 20th: PIKTOR preclinical data + breast cancer

Faeth Therapeutics October 20th Surge Interpretation

Keywords: PIKTOR preclinical data, breast cancer

On October 19th, the company announced that it will present PIKTOR preclinical data at ESMO 2026 on October 23rd. The content includes its effects as a monotherapy and in combination with fulvestrant, oral SERD, and CDK inhibitors, and compares it with giredestrant in two breast cancer xenograft models. The relevant data aims to support the further clinical development of PIKTOR in HR+/HER2− breast cancer.

(Disclaimer: This content is generated by AI summarizing publicly available information for reference only and does not constitute investment advice.)